The EPS projection of Hologic, Inc. (NASDAQ:HOLX) for quarter ended 2016-09-30 is $0.5. A week before, the EPS forecast was $0.5 against target of $0.5, a month earlier. This estimate stood at $0.5 60 days earlier versus forecast of $0.5 90 days earlier, confirming a deviation of 0%.
Hologic, Inc. (NASDAQ:HOLX) reported that 18 days ago, the positive EPS revisions were 5 and negative revisions at 0.
In last week, the per-share earnings was lowered 0 times and 0 times positively. In last 120, 60, 30 and 90 days the positive revisions were 4, 4, 1 and 4, respectively.
The downgrade of EPS estimates for Hologic, Inc. (NASDAQ:HOLX) in the preceding 120, 60, 30 and 90 days were 0, 0, 0 and 0, in that order.
As per the latest update, for the quarter closed 2, the EPS estimate of Hologic, Inc. (NASDAQ:HOLX) was $0.5. This projection was computed after accounting 11 calls. As reported on 2016-04-27 the EPS was $0.47. The change was $0.01, demonstrating a percentage deviation of 2.17%. The projections confirmed a standard deviation of 0.01.
Quarterly Sales Estimates
For the fiscal 2017, the yearly sales target for Hologic, Inc. (NASDAQ:HOLX) stands at $765.8 and the median estimate at $765.8. Almost 2 analysts announced their estimates.
The highest estimate is $765.9 while the lowest target is $765.7 showing standard deviation of 0.141%.
As many as 2 analysts released sales estimates reised in upside while 2 reduced sales estimates, demonstrating a deviation of 0%.
In last month, 2 revised sales number projection on upside while 2 lowered the sales target, demonstrating a deviation of 0%.
A quarter ago, 2 hiked sales estimations and 2 reduced sales forecast. Hologic, Inc. (NASDAQ:HOLX) stated that the change in forecast was -0.458%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...